---
schema_version: "secwatch.filing_event.v1"
accession: "0000937556-25-000003"
form_type: "8-K"
ticker: "MASI"
cik: "0000937556"
company_name: "MASIMO CORP"
filed_at: "2025-01-16T23:59:59+00:00"
generated_at: "2026-05-28T00:45:49.538901+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Masimo reports preliminary Q4 2024 revenue ~$601M, healthcare up 9%; issues FY 2025 guidance

## Summary
- Q4 2024 consolidated revenue ~$601M (+9% YoY); healthcare revenue ~$368M (+8% reported, +9% constant currency).
- FY 2024 consolidated revenue ~$2,094M (+2%); healthcare $1,395M (+9%); non-healthcare $699M (-10%).
- Non-GAAP EPS FY 2024 expected >$4.10 (high end of prior guidance range).
- FY 2025 healthcare revenue guidance $1,500M-$1,530M (8-11% constant currency growth); non-GAAP EPS $4.90-$5.10.
- Q4 shipments of noninvasive technology boards/instruments ~65K units.

## SEC filing metadata
- accession: 0000937556-25-000003
- form_type: 8-K
- ticker: MASI
- cik: 0000937556
- company_name: MASIMO CORP
- filed_at: 2025-01-16T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/0000937556-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/937556/000093755625000003/masi-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000937556-25-000003
- JSON: https://secwatch.observer/filing/0000937556-25-000003.json
- Plain text: https://secwatch.observer/filing/0000937556-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.